RFA-CA-22-002 - Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics NOT-CA-22-083 NCI Apr 26, 2022 Dec 31, 2024 R33, R61, R21, U24, U01
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology NOT-CA-22-003 NCI Nov 30, 2021 May 8, 2023 R03, R61, R33, R21

For technical issues E-mail OER Webmaster